Thanks to GLP-1s, Obesity Experts Are Trying to Understand ‘Food Noise’
The New York Times • • general
Key Points:
- Researchers developing obesity drugs like Ozempic and Wegovy initially focused on physical effects such as weight loss and improvements in conditions like diabetes, rather than psychological factors.
- Patients using GLP-1 drugs reported a significant reduction in "food noise," the constant internal thoughts and dialogues about eating, which they previously believed was a universal experience.
- The silencing of food noise by these drugs is prompting new research questions about the underlying causes of obesity and the psychological components of eating behavior.
- Individuals with long-term weight struggles, like Lena Smith Parker, describe persistent internal urges and shame related to food, highlighting the potential impact of these drugs on mental as well as physical aspects of obesity.
